Document Mentions (3 shared documents)

EFTA00135712

2 mentions1 same-page

Page ?Same page

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very dear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief for

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA00148896

2 mentions1 same-page

Page ?Same page

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very clear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief fo

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA01658495

2 mentions1 same-page

Page ?Same page

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very clear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief fo